Metastatic Lung Non-Small Cell Carcinoma
Oncology·MeSH: Lung Neoplasms
4 drugs in development·3 companies·10 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Ensartinib | ADMA BIOLOGICS, INC. (ADMA) |
Phase 1(1)
| Drug | Company |
|---|---|
| Pemetrexed | ADMA BIOLOGICS, INC. (ADMA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Lung Non-Small Cell Carcinoma?
BioSniper tracks 4 drugs in development for Metastatic Lung Non-Small Cell Carcinoma across 3 companies.
How many clinical trials target Metastatic Lung Non-Small Cell Carcinoma?
There are 10 clinical trials targeting Metastatic Lung Non-Small Cell Carcinoma tracked by BioSniper.
Deep-dive into Metastatic Lung Non-Small Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis